Boston Financial Mangement LLC decreased its stake in shares of Monsanto Company (NYSE:MON) by 7.6% during the second quarter, Holdings Channel reports. The fund owned 17,877 shares of the basic materials company’s stock after selling 1,464 shares during the period. Boston Financial Mangement LLC’s holdings in Monsanto were worth $2,116,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Rockland Trust Co. raised its position in Monsanto by 1.5% in the first quarter. Rockland Trust Co. now owns 119,378 shares of the basic materials company’s stock valued at $13,514,000 after buying an additional 1,814 shares during the period. Ledyard National Bank raised its position in Monsanto by 39.3% in the first quarter. Ledyard National Bank now owns 2,589 shares of the basic materials company’s stock valued at $293,000 after buying an additional 730 shares during the period. Hartford Financial Management Inc. purchased a new position in Monsanto during the first quarter valued at $113,000. Middleton & Co Inc MA raised its position in Monsanto by 2.3% in the first quarter. Middleton & Co Inc MA now owns 14,630 shares of the basic materials company’s stock valued at $1,656,000 after buying an additional 335 shares during the period. Finally, Whitnell & Co. raised its position in Monsanto by 35.4% in the first quarter. Whitnell & Co. now owns 979 shares of the basic materials company’s stock valued at $111,000 after buying an additional 256 shares during the period. Institutional investors and hedge funds own 75.28% of the company’s stock.

Shares of Monsanto Company (MON) opened at 117.02 on Wednesday. The firm’s 50-day moving average is $117.45 and its 200 day moving average is $115.27. The firm has a market cap of $51.41 billion, a PE ratio of 25.27 and a beta of 1.07. Monsanto Company has a 52 week low of $97.35 and a 52 week high of $118.97.

Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.74 by $0.19. The business had revenue of $4.23 billion during the quarter, compared to analyst estimates of $4.18 billion. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The company’s revenue was up 1.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.17 earnings per share. Equities research analysts forecast that Monsanto Company will post $4.89 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Friday, October 6th will be given a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.85%. The ex-dividend date of this dividend is Thursday, October 5th. Monsanto’s dividend payout ratio (DPR) is presently 46.75%.

COPYRIGHT VIOLATION NOTICE: This piece was originally published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece can be viewed at https://www.dailypolitical.com/2017/08/16/boston-financial-mangement-llc-decreases-position-in-monsanto-company-mon.html.

Several research firms have recently weighed in on MON. Piper Jaffray Companies set a $128.00 target price on shares of Monsanto and gave the company a “buy” rating in a report on Friday, August 11th. Vetr lowered shares of Monsanto from a “buy” rating to a “hold” rating and set a $122.35 target price for the company. in a report on Wednesday, August 2nd. Royal Bank Of Canada reaffirmed a “hold” rating and set a $128.00 target price on shares of Monsanto in a report on Wednesday, August 2nd. BidaskClub lowered shares of Monsanto from a “hold” rating to a “sell” rating in a report on Sunday, July 16th. Finally, Jefferies Group LLC lowered shares of Monsanto from a “buy” rating to a “hold” rating and set a $128.00 target price for the company. in a report on Wednesday, July 12th. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and eight have assigned a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $123.15.

In other news, EVP Steven Mizell sold 11,300 shares of the business’s stock in a transaction on Monday, July 3rd. The stock was sold at an average price of $118.57, for a total transaction of $1,339,841.00. Following the sale, the executive vice president now directly owns 55,011 shares of the company’s stock, valued at $6,522,654.27. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Janet M. Holloway sold 3,337 shares of the business’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $118.00, for a total value of $393,766.00. Following the sale, the senior vice president now directly owns 44,405 shares in the company, valued at $5,239,790. The disclosure for this sale can be found here. Insiders have sold 74,470 shares of company stock worth $8,791,281 over the last ninety days. 0.79% of the stock is owned by insiders.

Monsanto Company Profile

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.